Abstract:Depressive symptoms may either be a risk factor or prodromal to dementia. Investigating this association in midlife may help clarify the role of depression in cognitive aging. We aimed to identify trajectories in depressive symptoms in early to mid-life and related cognitive and brain outcomes in midlife. This study includes 3944 Black and White participants (ages 26−45 years at baseline) from the Coronary Artery Risk Development in Young Adults (CARDIA) study with 20 years of follow-up. Depressive symptoms were assessed using the Center for Epidemiological Studies Depression scale at five time points over 20 years. Growth mixture modeling (GMM) was used to identify depressive symptom trajectories. Participants completed a neuropsychological battery 20 years after baseline, including the Digit Symbol Substitution Test (DSST), Rey-Auditory Verbal Learning Test (RAVLT), Stroop Test, Montreal Cognitive Assessment (MoCA), and category and letter fluency tests. A sub-sample of participants ( n = 662) underwent brain magnetic resonance imaging (MRI) to characterize gray matter volumes and white matter hyperintensities (WMHs). We identified four classes of depressive symptom trajectories: a "declining" class ( n = 286, 7.3%) with initially high symptoms and subsequent decline, a class with consistently high symptoms ("steady high"; n = 264, 6.7%), a class with late increases in symptoms ("increasing"; n = 277, 7%), and a class with consistently low symptoms ("steady low"; n = 3117, 79.0%). The steady high and the increasing classes had poorer performance on all cognitive tests, while the declining class had poorer performance on the DSST, verbal fluency, and MoCA. Compared to the steady low symptom class, the steady high class had lower volumes in the entorhinal cortex (β: −180.80, 95% CI: −336.69 to −24.91) and the amygdala (β: −40.97, 95% CI: −74.09 to −7.85), the increasing class had more WMHs (β: 0.55, 95% CI: 0.22 to 0.89), and the declining class was not significantly different in any brain measures. Trajectories in depressive symptoms in young to mid-adulthood show distinct cognitive and brain phenotypes in midlife. Steady high depressive symptoms may represent a group that is at risk for dementia, whereas increasing symptoms in midlife may be associated with white matter damage.

Cognitive Trajectories and Alzheimer Disease Biomarkers: From Successful Cognitive Aging to Clinical Impairment

Cognitive Trajectories in Community-Dwelling Older Adults and Incident Dementia, Disability and Death: A 10-Year Longitudinal Study

Longitudinal Trajectories of Clinical Decline in Amyloid Positive and Negative Populations

Differential Cognitive Deterioration in Dementia: A Two Year Longitudinal Study

Uncovering Heterogeneous Cognitive Trajectories in Mild Cognitive Impairment: a Data-Driven Approach

Trajectories of Cognitive Decline in Different Domains Prior to AD onset in Persons with Mild Cognitive Impairment

Trajectories of cognitive function and their determinants in older people: 12 years of follow-up in the Chinese Longitudinal Healthy Longevity Survey

Estimating individual trajectories of structural and cognitive decline in mild cognitive impairment for early prediction of progression to dementia of the Alzheimer's type

The Association Between Cognitive Reserve and Cognitive Trajectories Among Older Adults

Longitudinal trajectories of cognitive reserve in hypometabolic subtypes of Alzheimer's disease

Clinical and Biomarker Trajectories in Sporadic Alzheimer's Disease: A Longitudinal Study

Disease trajectories in older adults with non-AD pathologic change and comparison with Alzheimer's disease pathophysiology: a longitudinal study

Cognitive trajectories in older adults and the role of depressive symptoms: A 7-year follow-up study

Trajectories in depressive symptoms and midlife brain health

Cognitive trajectories preluding the onset of different dementia entities: a descriptive longitudinal study using the NACC database

Disease Trajectories in Older Adults with Non-Ad Pathologic Change and Comparison with Alzheimer’s Disease Pathophysiology: A Longitudinal Study

Depressive symptoms and cognitive decline in older adults

Predictors and outcomes of fluctuations in the clinical dementia rating scale

C-27 Neuropsychological Differences in 10 Year Long-Term Stable Mild Cognitive Impairment and Converting Mild Cognitive Impairment

Timing of Alzheimer's disease biomarker progressions: A two‐decade observational study from the Alzheimer's Disease Neuroimaging Initiative (ADNI)

Differential trajectories of age-related changes in components of executive and memory processes.